Amy M. Kelaher

Combination Therapy in Treatment of Experimental Pulmonary Aspergillosis: Synergistic Interaction between an Antifungal Triazole and an Echinocandin

Vidmantas Petraitis, Rūta Petraitienė, Alia A. Sarafandi et al. · The Journal of Infectious Diseases · 2003 · 234 citations

Experimental Pulmonary Aspergillosis, Antifungal Agent, Antifungal Agents +10

The Pharmacokinetics and Pharmacodynamics of Micafungin in Experimental Hematogenous<i>Candida</i>Meningoencephalitis: Implications for Echinocandin Therapy in Neonates

William Hope, Diana Mickiene, Vidmantas Petraitis et al. · The Journal of Infectious Diseases · 2007 · 182 citations · Full text

Detection of Galactomannan Antigenemia in Patients Receiving Piperacillin-Tazobactam and Correlations between In Vitro, In Vivo, and Clinical Properties of the Drug-Antigen Interaction

Thomas J. Walsh, Shmuel Shoham, Rūta Petraitienė et al. · Journal of Clinical Microbiology · 2004 · 149 citations · Full text

Clinical Properties, Immunology, Pharmacotherapy +23

Pathogenesis of <i>Aspergillus fumigatus</i> and the Kinetics of Galactomannan in an In Vitro Model of Early Invasive Pulmonary Aspergillosis: Implications for Antifungal Therapy

William Hope, Michael J. Kruhlak, Caron A. Lyman et al. · The Journal of Infectious Diseases · 2007 · 128 citations · Full text

Triazole‐Polyene Antagonism in Experimental Invasive Pulmonary Aspergillosis: In Vitro and In Vivo Correlation

Joseph Meletiadis, Vidmantas Petraitis, Rūta Petraitienė et al. · The Journal of Infectious Diseases · 2006 · 106 citations · Full text

Vivo Correlation, Vivo Antagonism, Pharmaceutical Science +13